BCR-ABL1 mutation ≠ ponatinib resistance

被引:4
|
作者
Saglio, Giuseppe [1 ]
Fava, Carmen [1 ]
机构
[1] Univ Turin, I-10124 Turin, Italy
关键词
CHRONIC MYELOID-LEUKEMIA; CHROMOSOME-POSITIVE LEUKEMIAS; INHIBITOR; AP24534; POTENT;
D O I
10.1182/blood-2015-12-685149
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:666 / +
页数:2
相关论文
共 50 条
  • [41] BCR-ABL1 kinase domain mutations: Methodology and clinical evaluation
    Alikian, Mary
    Gerrard, Gareth
    Subramanian, Papagudi G.
    Mudge, Katherine
    Foskett, Pierre
    Khorashad, Jamshid Sorouri
    Lim, Ai Chiin
    Marin, David
    Milojkovic, Dragana
    Reid, Alistair
    Rezvani, Katy
    Goldman, John
    Apperley, Jane
    Foroni, Letizia
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (03) : 298 - 304
  • [42] A coiled-coil mimetic intercepts BCR-ABL1 dimerization
    Woessner, D. W.
    Eiring, A. M.
    Bruno, B. J.
    Zabriskie, M. S.
    Reynolds, K. R.
    Miller, G. D.
    O'Hare, T.
    Deininger, M. W.
    Lim, C. S.
    LEUKEMIA, 2015, 29 (08) : 1668 - 1675
  • [43] Atypical myeloproliferative neoplasm with concurrent BCR-ABL1 fusion and CALR mutation: A case report and literature review
    Liu, Chunshui
    Hu, Ruiping
    Du, Zhonghua
    Abecasis, Manuel
    Wang, Cong
    MEDICINE, 2020, 99 (05) : E18811
  • [44] Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India
    Rabade, Nikhil
    Subramanian, P. G.
    Kodgule, Rohan
    Raval, Goutham
    Joshi, Swapnali
    Chaudhary, Shruti
    Mascarenhas, Russel
    Tembhare, Prashant
    Gujral, Sumeet
    Patkar, Nikhil
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (02) : 209 - 213
  • [45] Low prevalence of the BCR-ABL1 fusion gene in a normal population in southern Sarawak
    Kuan, Jew Win
    Su, Anselm Ting
    Tay, Siow Phing
    Fong, Isabel Lim
    Kubota, Sho
    Su'ut, Lela
    Osato, Motomi
    Sashida, Goro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (02) : 217 - 224
  • [46] BCR-ABL1 in leukemia: Disguise master outplays riding shotgun
    Rana, Aamir
    Ali, Ghulam M.
    Ali, Shaukat
    Khan, Ammara
    Mansoor, Sajid
    Malik, Shazia
    Farooqi, Ammad A.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2013, 9 (01) : 6 - 10
  • [47] MXD1 regulates the imatinib resistance of chronic myeloid leukemia cells by repressing BCR-ABL1 expression
    Chen Huan
    Lou Jin
    Wang Heng
    An Na
    Pan Yuming
    Du Xin
    Zhang Qiaoxia
    LEUKEMIA RESEARCH, 2018, 75 : 1 - 6
  • [48] Contributions of MET activation to BCR-ABL1 tyrosine kinase inhibitor resistance in chronic myeloid leukemia cells
    Tsubaki, Masanobu
    Takeda, Tomoya
    Kino, Toshiki
    Sakai, Kazuko
    Itoh, Tatsuki
    Imano, Motohiro
    Nakayama, Takashi
    Nishio, Kazuto
    Satou, Takao
    Nishida, Shozo
    ONCOTARGET, 2017, 8 (24) : 38717 - 38730
  • [49] BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia
    Amarante-Mendes, Gustavo P.
    Rana, Aamir
    Datoguia, Tarcila Santos
    Hamerschlak, Nelson
    Brumatti, Gabriela
    PHARMACEUTICS, 2022, 14 (01)
  • [50] Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended
    Huet, Sarah
    Cony-Makhoul, Pascale
    Heiblig, Mael
    Tigaud, Isabelle
    Gazzo, Sophie
    Belhabri, Amine
    Souche, Denis
    Michallet, Mauricette
    Magaud, Jean-Pierre
    Hayette, Sandrine
    Nicolini, Franck
    PLOS ONE, 2014, 9 (09):